APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amiodarone Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Amiodarone Injection Market Outlook and Growth Opportunities 2026

2 January 2026196 pages

Choose your research edition.

Industry ResearchAmiodarone Injection Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Amiodarone Injection Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Amiodarone Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amiodarone Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Amiodarone Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Amiodarone Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Amiodarone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Amiodarone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amiodarone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Amiodarone Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Amiodarone Injection market include AuroMedics, Bioniche Pharma, Hikma, Prism Pharmaceutical, Sagent, Baxter, Fangming Pharmaceutical Group, Fresenius Kabi and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Amiodarone Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Amiodarone Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Amiodarone Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amiodarone Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Amiodarone Injection Segment by Company

AuroMedics

Bioniche Pharma

Hikma

Prism Pharmaceutical

Sagent

Baxter

Fangming Pharmaceutical Group

Fresenius Kabi

Mylan

Sanofi

Amiodarone Injection Segment by Type

15mg/ml

50mg/ml

Amiodarone Injection Segment by Application

Clinics

Hospital

Recovery Center

Amiodarone Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Amiodarone Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Amiodarone Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Amiodarone Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Amiodarone Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amiodarone Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amiodarone Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amiodarone Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Amiodarone Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Amiodarone Injection industry.

Chapter 3: Detailed analysis of Amiodarone Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Amiodarone Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Amiodarone Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Amiodarone Injection Industry Trends Table 2. Amiodarone Injection Industry Drivers Table 3. Amiodarone Injection Industry Opportunities and Challenges Table 4. Amiodarone Injection Industry Restraints Table 5. Global Amiodarone Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Amiodarone Injection Revenue Share by Company (2021-2026) Table 7. Global Amiodarone Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Amiodarone Injection Sales Volume Share by Company (2021-2026) Table 9. Global Amiodarone Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Amiodarone Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Amiodarone Injection Key Company Manufacturing Base & Headquarters Table 12. Global Amiodarone Injection Company, Product Type & Application Table 13. Global Amiodarone Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Amiodarone Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 15mg/ml Table 18. Significant Companies of 50mg/ml Table 19. Global Amiodarone Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Amiodarone Injection Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Amiodarone Injection Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Amiodarone Injection Sales Volume Share by Type (2021-2026) Table 23. Global Amiodarone Injection Sales Volume Share by Type (2027-2032) Table 24. Global Amiodarone Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Amiodarone Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Amiodarone Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Amiodarone Injection Sales Value Share by Type (2021-2026) Table 28. Global Amiodarone Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Clinics Table 30. Significant Companies of Hospital Table 31. Significant Companies of Recovery Center Table 32. Global Amiodarone Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Amiodarone Injection Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Amiodarone Injection Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Amiodarone Injection Sales Volume Share by Application (2021-2026) Table 36. Global Amiodarone Injection Sales Volume Share by Application (2027-2032) Table 37. Global Amiodarone Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Amiodarone Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Amiodarone Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Amiodarone Injection Sales Value Share by Application (2021-2026) Table 41. Global Amiodarone Injection Sales Value Share by Application (2027-2032) Table 42. Global Amiodarone Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Amiodarone Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Amiodarone Injection Sales Market Share by Region (2021-2026) Table 45. Global Amiodarone Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Amiodarone Injection Sales Market Share by Region (2027-2032) Table 47. Global Amiodarone Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Amiodarone Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Amiodarone Injection Sales Value Share by Region (2021-2026) Table 50. Global Amiodarone Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Amiodarone Injection Sales Value Share by Region (2027-2032) Table 52. Global Amiodarone Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Amiodarone Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Amiodarone Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Amiodarone Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Amiodarone Injection Sales by Country (2021-2026) & (K Units) Table 57. Global Amiodarone Injection Sales Market Share by Country (2021-2026) Table 58. Global Amiodarone Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Amiodarone Injection Sales Market Share by Country (2027-2032) Table 60. Global Amiodarone Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Amiodarone Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Amiodarone Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Amiodarone Injection Sales Value Market Share by Country (2027-2032) Table 64. AuroMedics Company Information Table 65. AuroMedics Business Overview Table 66. AuroMedics Amiodarone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. AuroMedics Amiodarone Injection Product Portfolio Table 68. AuroMedics Recent Development Table 69. Bioniche Pharma Company Information Table 70. Bioniche Pharma Business Overview Table 71. Bioniche Pharma Amiodarone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Bioniche Pharma Amiodarone Injection Product Portfolio Table 73. Bioniche Pharma Recent Development Table 74. Hikma Company Information Table 75. Hikma Business Overview Table 76. Hikma Amiodarone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Hikma Amiodarone Injection Product Portfolio Table 78. Hikma Recent Development Table 79. Prism Pharmaceutical Company Information Table 80. Prism Pharmaceutical Business Overview Table 81. Prism Pharmaceutical Amiodarone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Prism Pharmaceutical Amiodarone Injection Product Portfolio Table 83. Prism Pharmaceutical Recent Development Table 84. Sagent Company Information Table 85. Sagent Business Overview Table 86. Sagent Amiodarone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sagent Amiodarone Injection Product Portfolio Table 88. Sagent Recent Development Table 89. Baxter Company Information Table 90. Baxter Business Overview Table 91. Baxter Amiodarone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Baxter Amiodarone Injection Product Portfolio Table 93. Baxter Recent Development Table 94. Fangming Pharmaceutical Group Company Information Table 95. Fangming Pharmaceutical Group Business Overview Table 96. Fangming Pharmaceutical Group Amiodarone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Fangming Pharmaceutical Group Amiodarone Injection Product Portfolio Table 98. Fangming Pharmaceutical Group Recent Development Table 99. Fresenius Kabi Company Information Table 100. Fresenius Kabi Business Overview Table 101. Fresenius Kabi Amiodarone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Fresenius Kabi Amiodarone Injection Product Portfolio Table 103. Fresenius Kabi Recent Development Table 104. Mylan Company Information Table 105. Mylan Business Overview Table 106. Mylan Amiodarone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Mylan Amiodarone Injection Product Portfolio Table 108. Mylan Recent Development Table 109. Sanofi Company Information Table 110. Sanofi Business Overview Table 111. Sanofi Amiodarone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Sanofi Amiodarone Injection Product Portfolio Table 113. Sanofi Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Amiodarone Injection Distributors List Table 117. Amiodarone Injection Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Amiodarone Injection Product Image Figure 2. Global Amiodarone Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amiodarone Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Amiodarone Injection Sales (2021-2032) & (K Units) Figure 5. Global Amiodarone Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Amiodarone Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 15mg/ml Image Figure 10. 50mg/ml Image Figure 11. Global Amiodarone Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Amiodarone Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Amiodarone Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Amiodarone Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Amiodarone Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Amiodarone Injection Sales Value Share by Type (2021-2032) Figure 17. Clinics Image Figure 18. Hospital Image Figure 19. Recovery Center Image Figure 20. Global Amiodarone Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Amiodarone Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Amiodarone Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Amiodarone Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Amiodarone Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Amiodarone Injection Sales Value Share by Application (2021-2032) Figure 26. Global Amiodarone Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Amiodarone Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Amiodarone Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Amiodarone Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Amiodarone Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Amiodarone Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Amiodarone Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Amiodarone Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Amiodarone Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Amiodarone Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Amiodarone Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Amiodarone Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Amiodarone Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Amiodarone Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Amiodarone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Amiodarone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Amiodarone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Amiodarone Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Amiodarone Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 15mg/ml
  • 50mg/ml
Applications
  • Clinics
  • Hospital
  • Recovery Center
Companies covered
  • AuroMedics
  • Bioniche Pharma
  • Hikma
  • Prism Pharmaceutical
  • Sagent
  • Baxter
  • Fangming Pharmaceutical Group
  • Fresenius Kabi
  • Mylan
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Amiodarone Injection Sales Value (2021-2032)
  4. 1.2.2 Global Amiodarone Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Amiodarone Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Amiodarone Injection Market Dynamics
  1. 2.1 Amiodarone Injection Industry Trends
  2. 2.2 Amiodarone Injection Industry Drivers
  3. 2.3 Amiodarone Injection Industry Opportunities and Challenges
  4. 2.4 Amiodarone Injection Industry Restraints
3 Amiodarone Injection Market by Company
  1. 3.1 Global Amiodarone Injection Company Revenue Ranking in 2025
  2. 3.2 Global Amiodarone Injection Revenue by Company (2021-2026)
  3. 3.3 Global Amiodarone Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Amiodarone Injection Average Price by Company (2021-2026)
  5. 3.5 Global Amiodarone Injection Company Ranking (2024-2026)
  6. 3.6 Global Amiodarone Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Amiodarone Injection Company Product Type and Application
  8. 3.8 Global Amiodarone Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Amiodarone Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Amiodarone Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Amiodarone Injection Market by Type
  1. 4.1 Amiodarone Injection Type Introduction
  2. 4.1.1 15mg/ml
  3. 4.1.2 50mg/ml
  4. 4.2 Global Amiodarone Injection Sales Volume by Type
  5. 4.2.1 Global Amiodarone Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Amiodarone Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Amiodarone Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Amiodarone Injection Sales Value by Type
  9. 4.3.1 Global Amiodarone Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Amiodarone Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Amiodarone Injection Sales Value Share by Type (2021-2032)
5 Amiodarone Injection Market by Application
  1. 5.1 Amiodarone Injection Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Amiodarone Injection Sales Volume by Application
  6. 5.2.1 Global Amiodarone Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Amiodarone Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Amiodarone Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Amiodarone Injection Sales Value by Application
  10. 5.3.1 Global Amiodarone Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Amiodarone Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Amiodarone Injection Sales Value Share by Application (2021-2032)
6 Amiodarone Injection Regional Sales and Value Analysis
  1. 6.1 Global Amiodarone Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Amiodarone Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Amiodarone Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Amiodarone Injection Sales by Region (2027-2032)
  5. 6.3 Global Amiodarone Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Amiodarone Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Amiodarone Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Amiodarone Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Amiodarone Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Amiodarone Injection Sales Value (2021-2032)
  12. 6.6.2 North America Amiodarone Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Amiodarone Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Amiodarone Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Amiodarone Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Amiodarone Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Amiodarone Injection Sales Value (2021-2032)
  21. 6.9.2 South America Amiodarone Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Amiodarone Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Amiodarone Injection Sales Value Share by Country, 2025 VS 2032
7 Amiodarone Injection Country-level Sales and Value Analysis
  1. 7.1 Global Amiodarone Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Amiodarone Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Amiodarone Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Amiodarone Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Amiodarone Injection Sales by Country (2027-2032)
  6. 7.4 Global Amiodarone Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Amiodarone Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Amiodarone Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Amiodarone Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Amiodarone Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Amiodarone Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Amiodarone Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Amiodarone Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Amiodarone Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Amiodarone Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Amiodarone Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Amiodarone Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Amiodarone Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Amiodarone Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Amiodarone Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Amiodarone Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Amiodarone Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Amiodarone Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Amiodarone Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Amiodarone Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Amiodarone Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Amiodarone Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Amiodarone Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Amiodarone Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Amiodarone Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Amiodarone Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Amiodarone Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Amiodarone Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Amiodarone Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Amiodarone Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Amiodarone Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Amiodarone Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Amiodarone Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AuroMedics
  2. 8.1.1 AuroMedics Company Information
  3. 8.1.2 AuroMedics Business Overview
  4. 8.1.3 AuroMedics Amiodarone Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AuroMedics Amiodarone Injection Product Portfolio
  6. 8.1.5 AuroMedics Recent Developments
  7. 8.2 Bioniche Pharma
  8. 8.2.1 Bioniche Pharma Company Information
  9. 8.2.2 Bioniche Pharma Business Overview
  10. 8.2.3 Bioniche Pharma Amiodarone Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bioniche Pharma Amiodarone Injection Product Portfolio
  12. 8.2.5 Bioniche Pharma Recent Developments
  13. 8.3 Hikma
  14. 8.3.1 Hikma Company Information
  15. 8.3.2 Hikma Business Overview
  16. 8.3.3 Hikma Amiodarone Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hikma Amiodarone Injection Product Portfolio
  18. 8.3.5 Hikma Recent Developments
  19. 8.4 Prism Pharmaceutical
  20. 8.4.1 Prism Pharmaceutical Company Information
  21. 8.4.2 Prism Pharmaceutical Business Overview
  22. 8.4.3 Prism Pharmaceutical Amiodarone Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Prism Pharmaceutical Amiodarone Injection Product Portfolio
  24. 8.4.5 Prism Pharmaceutical Recent Developments
  25. 8.5 Sagent
  26. 8.5.1 Sagent Company Information
  27. 8.5.2 Sagent Business Overview
  28. 8.5.3 Sagent Amiodarone Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sagent Amiodarone Injection Product Portfolio
  30. 8.5.5 Sagent Recent Developments
  31. 8.6 Baxter
  32. 8.6.1 Baxter Company Information
  33. 8.6.2 Baxter Business Overview
  34. 8.6.3 Baxter Amiodarone Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Baxter Amiodarone Injection Product Portfolio
  36. 8.6.5 Baxter Recent Developments
  37. 8.7 Fangming Pharmaceutical Group
  38. 8.7.1 Fangming Pharmaceutical Group Company Information
  39. 8.7.2 Fangming Pharmaceutical Group Business Overview
  40. 8.7.3 Fangming Pharmaceutical Group Amiodarone Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Fangming Pharmaceutical Group Amiodarone Injection Product Portfolio
  42. 8.7.5 Fangming Pharmaceutical Group Recent Developments
  43. 8.8 Fresenius Kabi
  44. 8.8.1 Fresenius Kabi Company Information
  45. 8.8.2 Fresenius Kabi Business Overview
  46. 8.8.3 Fresenius Kabi Amiodarone Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Fresenius Kabi Amiodarone Injection Product Portfolio
  48. 8.8.5 Fresenius Kabi Recent Developments
  49. 8.9 Mylan
  50. 8.9.1 Mylan Company Information
  51. 8.9.2 Mylan Business Overview
  52. 8.9.3 Mylan Amiodarone Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Mylan Amiodarone Injection Product Portfolio
  54. 8.9.5 Mylan Recent Developments
  55. 8.10 Sanofi
  56. 8.10.1 Sanofi Company Information
  57. 8.10.2 Sanofi Business Overview
  58. 8.10.3 Sanofi Amiodarone Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Amiodarone Injection Product Portfolio
  60. 8.10.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Amiodarone Injection Value Chain Analysis
  2. 9.1.1 Amiodarone Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Amiodarone Injection Sales Mode & Process
  6. 9.2 Amiodarone Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Amiodarone Injection Distributors
  9. 9.2.3 Amiodarone Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst